Form 4: Danaher Corp Executive Matthew McGrew Reports Stock Transactions
SEC Form 4 Filing
Matthew McGrew, EVP & Chief Financial Officer of Danaher Corp, reports the acquisition and disposal of common stock and the exercise of employee stock options.
Summary
- On May 10, 2024, Matthew McGrew, EVP & Chief Financial Officer of Danaher Corp, reported transactions involving Danaher's common stock and employee stock options.
- McGrew sold 21,203 shares of common stock at a weighted average price of $253.0752.
- He also exercised options to acquire 9,243 shares at $58.48 and sold those shares at a weighted average price of $253.1901.
- Additionally, McGrew exercised options to acquire 15,931 shares at $62.85 and sold those shares at a weighted average price of $252.945.
- Following these transactions, McGrew directly owns 29,407 shares of common stock and indirectly owns 8,798.63 shares through a 401(k).
- He also holds 32,344 employee stock options.
Sentiment
Score: 5
Explanation: The document is a neutral report of stock transactions. There is no inherent positive or negative sentiment associated with the information.
Industry Context
This filing is a routine disclosure of insider transactions, which are common for executives of publicly traded companies. These transactions can be influenced by various factors, including personal financial planning and company performance.
Comparison to Industry Standards
- Executive compensation packages often include stock options as a form of long-term incentive.
- The exercise and sale of these options are typical events and are usually disclosed via Form 4 filings.
- Comparing McGrew's transactions to those of executives at similar companies (e.g., Thermo Fisher Scientific, Abbott Laboratories) would require analyzing their respective Form 4 filings for similar periods.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership.
- The impact is likely minimal as the transactions are part of normal executive compensation and financial planning.
Key Dates
| Date | Description |
|---|---|
| 02/24/2015 | Grant date of employee stock options, one fifth of which became exercisable on each of the first five anniversaries of the grant date. |
| 11/15/2015 | Grant date of employee stock options, one third of which became exercisable on each of the third, fourth and fifth anniversaries of the grant date. |
| 05/10/2024 | Date of the reported transactions: stock sales and option exercises. |
| 05/13/2024 | Date of the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.